688767 博拓生物
已收盘 05-15 15:00:00
资讯
新帖
简况
【机构调研记录】安信基金调研博拓生物、开立医疗等3只个股(附名单)
证券之星 · 05-14 08:01
【机构调研记录】安信基金调研博拓生物、开立医疗等3只个股(附名单)
博拓生物(688767.SH):目前POCT行业竞争较为激烈 POCT产品面临一定降价压力
格隆汇资讯 · 05-13 16:15
博拓生物(688767.SH):目前POCT行业竞争较为激烈 POCT产品面临一定降价压力
博拓生物跌破20元 主力净流出951万
智选洞察 · 05-13 14:12
博拓生物跌破20元 主力净流出951万
博拓生物:副总经理杨军退休辞任
每日经济新闻 · 04-30
博拓生物:副总经理杨军退休辞任
博拓生物:累计回购约211万股
每日经济新闻 · 04-30
博拓生物:累计回购约211万股
博拓生物(688767.SH)累计回购1.98%股份 耗资5693.02万元
智通财经 · 04-30
博拓生物(688767.SH)累计回购1.98%股份 耗资5693.02万元
博拓生物创3月新高 高精尖技术产品首发会举行
智选洞察 · 04-30
博拓生物创3月新高 高精尖技术产品首发会举行
博拓生物今年一季度归母净利润同比增长233.05%
新京报 · 04-28
博拓生物今年一季度归母净利润同比增长233.05%
博拓生物2023年营收4.42亿净利1.07亿 董事长陈音龙薪酬80.11万
挖贝网 · 04-28
博拓生物2023年营收4.42亿净利1.07亿 董事长陈音龙薪酬80.11万
博拓生物(688767)3月31日股东户数0.77万户,较上期减少12%
证券之星 · 04-27
博拓生物(688767)3月31日股东户数0.77万户,较上期减少12%
博拓生物:2024年第一季度净利润约3963万元
每日经济新闻 · 04-27
博拓生物:2024年第一季度净利润约3963万元
图解博拓生物年报:第四季度单季净利润同比增113.57%
证券之星 · 04-27
图解博拓生物年报:第四季度单季净利润同比增113.57%
博拓生物(688767.SH)发2023年度业绩,净利润1.07亿元,同比减少86.22%
智通财经网 · 04-26
博拓生物(688767.SH)发2023年度业绩,净利润1.07亿元,同比减少86.22%
博拓生物(688767.SH)发一季度业绩,净利润3963.13万元,同比增长233.05%
智通财经 · 04-26
博拓生物(688767.SH)发一季度业绩,净利润3963.13万元,同比增长233.05%
博拓生物04月22日主力资金流入26万元 连续5日加仓
自选股智能写手 · 04-22
博拓生物04月22日主力资金流入26万元 连续5日加仓
博拓生物上涨5.38%,报24.89元/股
金融界网站 · 04-17
博拓生物上涨5.38%,报24.89元/股
博拓生物大幅上涨5.38% 主力净流入270万元
智选洞察 · 04-17
博拓生物大幅上涨5.38% 主力净流入270万元
博拓生物大跌5.42% 主力净流入增加
智选洞察 · 04-16
博拓生物大跌5.42% 主力净流入增加
加载更多
公司概况
公司名称:
杭州博拓生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-09-08
主营业务:
杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。2023年5月,公司成为浙江省2023年度第一批“专精特新”企业。
发行价格:
34.55
{"stockData":{"symbol":"688767","market":"SH","secType":"STK","nameCN":"博拓生物","latestPrice":28.87,"timestamp":1715756400000,"preClose":29.39,"halted":0,"volume":601559,"delay":0,"floatShares":40266700,"shares":107000000,"eps":1.2595,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.52,"latestTime":"05-15 15:00:00","open":29.36,"high":29.37,"low":28.75,"amount":17465000,"amplitude":0.0211,"askPrice":28.91,"askSize":2,"bidPrice":28.87,"bidSize":23,"shortable":0,"etf":0,"ttmEps":1.2595,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715823000000},"adr":0,"adjPreClose":29.39,"symbolType":"stock_kcb","openAndCloseTimeList":[[1715736600000,1715743800000],[1715749200000,1715756400000]],"highLimit":32.33,"lowLimit":26.45,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":106666667,"pbRate":1.27,"roa":"--","roe":"1.64%","epsLYR":1,"committee":-0.630499,"marketValue":3079000000,"floatMarketCap":1162000000,"peRate":22.921794,"changeRate":-0.0177,"turnoverRate":0.0149,"status":1,"afterMarket":{"amount":0,"volume":0,"close":28.87,"buyVolume":0,"sellVolume":0,"time":1715758439505,"indexStatus":"已收盘 05-15 15:30:00","preClose":29.39}},"requestUrl":"/m/hq/s/688767","defaultTab":"news","newsList":[{"id":"2435997582","title":"【机构调研记录】安信基金调研博拓生物、开立医疗等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435997582","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435997582?lang=zh_cn&edition=full","pubTime":"2024-05-14 08:01","pubTimestamp":1715644914,"startTime":"0","endTime":"0","summary":"3)宇瞳光学 个股亮点:宇瞳转债于2023-08-29上市;公司产品主要应用领域为安防视频监控;公司光学镜头在AR/VR有小批量出货。安信基金成立于2011年,截至目前,资产管理规模1139.54亿元,排名54/203;资产管理规模992.53亿元,排名47/203;管理公募基金数170只,排名36/203;旗下公募基金经理33人,排名36/203。旗下最近一年表现最佳的公募基金产品为安信永宁一年定开债发起式,最新单位净值为1.04,近一年增长8.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400004251.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435346341","title":"博拓生物(688767.SH):目前POCT行业竞争较为激烈 POCT产品面临一定降价压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2435346341","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2435346341?lang=zh_cn&edition=full","pubTime":"2024-05-13 16:15","pubTimestamp":1715588122,"startTime":"0","endTime":"0","summary":"格隆汇5月13日丨博拓生物(688767.SH)近日在接待机构投资者调研时表示,目前POCT行业竞争较为激烈,POCT产品面临一定降价压力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131615368b009f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131615368b009f0a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435311193","title":"博拓生物跌破20元 主力净流出951万","url":"https://stock-news.laohu8.com/highlight/detail?id=2435311193","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2435311193?lang=zh_cn&edition=full","pubTime":"2024-05-13 14:12","pubTimestamp":1715580757,"startTime":"0","endTime":"0","summary":"05月13日,博拓生物股价大幅下跌,截至14点12分,博拓生物下跌5.40%,报29.25元/股,突破20元整数关口,成交3526万元,换手率2.89%,振幅6.37%。资金动向截止发稿,博拓生物获得主力净流出951万元,其中超大单流出226万元,大单流出724万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示,今年一季报,博拓生物实现营业收入1.36亿元,同比增长30.81%,净利润为3,963.13万元,同比增长233.05%,基本每股收益为0.38元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131413137a59815a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131413137a59815a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431215394","title":"博拓生物:副总经理杨军退休辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2431215394","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431215394?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:06","pubTimestamp":1714468012,"startTime":"0","endTime":"0","summary":"博拓生物(SH 688767,收盘价:28.64元)4月30日晚间发布公告称,公司董事会于近日收到公司副总经理杨军先生辞去副总经理职务的书面报告。杨军先生因达到法定退休年龄申请辞去公司副总经理职务,辞职后杨军先生不再担任公司任何职务。杨军先生的辞任报告自送达公司董事会时生效。2023年1至12月份,博拓生物的营业收入构成为:体外诊断试纸占比98.6%。截至发稿,博拓生物市值为31亿元。文章来源:每日经济新闻原标题:博拓生物:副总经理杨军退休辞任","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043017192187c32a9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043017192187c32a9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431217394","title":"博拓生物:累计回购约211万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431217394","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431217394?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:06","pubTimestamp":1714468007,"startTime":"0","endTime":"0","summary":"博拓生物(SH 688767,收盘价:28.64元)4月30日晚间发布公告称,截至2024年4月30日,公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份约211万股,占公司总股本约1.07亿股的比例为1.978%,回购成交的最高价为33.48元/股,最低价为22.23元/股,支付的资金总额为人民币约5693万元。2023年1至12月份,博拓生物的营业收入构成为:体外诊断试纸占比98.6%。截至发稿,博拓生物市值为31亿元。文章来源:每日经济新闻原标题:博拓生物:累计回购约211万股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301709428b659e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301709428b659e7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431395656","title":"博拓生物(688767.SH)累计回购1.98%股份 耗资5693.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431395656","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431395656?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:45","pubTimestamp":1714466714,"startTime":"0","endTime":"0","summary":"智通财经APP讯,博拓生物(688767.SH)公告,截至2024年4月30日,公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份210.98万股,占公司总股本106,666,667股的比例为1.98%,回购成交的最高价为33.48元/股,最低价为22.23元/股,支付的资金总额为人民币5693.02万元(不含印花税、交易佣金等交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116227.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431568143","title":"博拓生物创3月新高 高精尖技术产品首发会举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431568143","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2431568143?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:25","pubTimestamp":1714454716,"startTime":"0","endTime":"0","summary":"04月30日,博拓生物股价大幅上涨,截至13点25分,博拓生物上涨5.01%,报28.73元/股,创近3月新高,成交3721万元,换手率3.28%。消息解读2024年4月28日,中关村论坛迎来了高精尖技术产品首发会“高端医疗器械专场”活动,8个《百项新技术新产品榜单》高端医疗器械领域的优秀参评项目,进行了现场首发。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430132705792560f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430132705792560f5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430054133","title":"博拓生物今年一季度归母净利润同比增长233.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430054133","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2430054133?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:48","pubTimestamp":1714308514,"startTime":"0","endTime":"0","summary":"归属于上市公司股东的扣除非经常性损益的净利润同比增长335.55%。2023年,受新冠疫情常态化后新冠检测试剂产品销售收入同比大幅减少的影响,博拓生物净利润同比大幅下滑。2024年第一季度,博拓生物业绩回升,报告期内流感相关产品收入增长,为营收增长提供动力。与此同时,博拓生物利息收入增长与销售收入增长,推动归母净利润的增长。随着临床试验投入增加,报告期内研发投入也同比增长48.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042820500287badffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042820500287badffa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430703457","title":"博拓生物2023年营收4.42亿净利1.07亿 董事长陈音龙薪酬80.11万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430703457","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430703457?lang=zh_cn&edition=full","pubTime":"2024-04-28 09:56","pubTimestamp":1714269389,"startTime":"0","endTime":"0","summary":"挖贝网4月28日,博拓生物 近日发布2023年年度报告,报告期内公司实现营业收入442,110,404.25元,同比下滑76.75%;归属于上市公司股东的净利润106,605,811.85元,同比下滑86.22%。报告期内经营活动产生的现金流量净额为131,380,776.97元,归属于上市公司股东的净资产2,415,243,484.16元。公告显示,报告期内董事、监事、高级管理人员报酬合计837.10万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042809574787b907e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042809574787b907e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430903177","title":"博拓生物(688767)3月31日股东户数0.77万户,较上期减少12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430903177","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430903177?lang=zh_cn&edition=full","pubTime":"2024-04-27 17:13","pubTimestamp":1714209191,"startTime":"0","endTime":"0","summary":"证券之星消息,近日博拓生物披露,截至2024年3月31日公司股东户数为7673.0户,较12月31日减少1046.0户,减幅为12.0%。在医疗器械行业个股中,博拓生物股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.09万户。从股价来看,2023年12月31日至2024年3月31日,博拓生物区间跌幅为14.83%,在此期间股东户数减少1046.0户,减幅为12.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271718458b5a2c95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271718458b5a2c95&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430275569","title":"博拓生物:2024年第一季度净利润约3963万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430275569","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430275569?lang=zh_cn&edition=full","pubTime":"2024-04-27 07:41","pubTimestamp":1714174860,"startTime":"0","endTime":"0","summary":"博拓生物(SH 688767,收盘价:25.41元)4月27日发布一季度业绩公告称,2024年第一季度营收约1.36亿元,同比增加30.81%;归属于上市公司股东的净利润约3963万元,同比增加233.05%;基本每股收益0.38元,同比增加245.45%。博拓生物的董事长是陈音龙,男,62岁,学历背景为大专;总经理是吴淑江,男,47岁,学历背景为硕士。(文章来源:每日经济新闻)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042707441287b5546d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042707441287b5546d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430783657","title":"图解博拓生物年报:第四季度单季净利润同比增113.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430783657","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430783657?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:36","pubTimestamp":1714149362,"startTime":"0","endTime":"0","summary":"证券之星消息,博拓生物2023年年报显示,公司主营收入4.42亿元,同比下降76.75%;归母净利润1.07亿元,同比下降86.22%;扣非净利润7942.52万元,同比下降89.5%;其中2023年第四季度,公司单季度主营收入1.3亿元,同比下降10.11%;单季度归母净利润1507.79万元,同比上升113.57%;单季度扣非净利润356.95万元,同比上升103.22%;负债率6.16%,投资收益337.99万元,财务费用-8576.12万元,毛利率50.33%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270049258b57f552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270049258b57f552&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430622715","title":"博拓生物(688767.SH)发2023年度业绩,净利润1.07亿元,同比减少86.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430622715","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430622715?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:02","pubTimestamp":1714129345,"startTime":"0","endTime":"0","summary":"智通财经APP讯,博拓生物(688767.SH)发布2023年年度报告,报告期内公司实现营业收入4.42亿元,同比减少76.75%;归属于上市公司股东的净利润1.07亿元,同比减少86.22%;归属于上市公司股东扣除非经常性损益净利润7942.52万元,同比减少89.50%;基本每股收益1.00元/股。公司拟向全体股东每10股派发现金红利8.00元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261905158b56f286&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261905158b56f286&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430122213","title":"博拓生物(688767.SH)发一季度业绩,净利润3963.13万元,同比增长233.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430122213","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430122213?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:58","pubTimestamp":1714129139,"startTime":"0","endTime":"0","summary":"智通财经APP讯,博拓生物(688767.SH)发布2024年第一季度报告,报告期内公司实现营业收入1.36亿元,同比增长30.81%;归属于上市公司股东的净利润3963.13万元,同比增长233.05%;归属于上市公司股东扣除非经常性损益净利润3943.97万元,同比增长335.55%;基本每股收益0.38元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111977.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429916682","title":"博拓生物04月22日主力资金流入26万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429916682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429916682?lang=zh_cn&edition=full","pubTime":"2024-04-22 15:19","pubTimestamp":1713770377,"startTime":"0","endTime":"0","summary":"04月22日, 博拓生物股价涨1.22%,报收24.85元,成交金额540万元,换手率0.54%,振幅3.22%,量比0.46。博拓生物今日主力资金净流入26万元,连续5日净流入,上一交易日主力净流入75万元,今日环比减少65.33%。该股近5个交易日上涨2.73%,主力资金累计净流入631万元,其中3个交易日为股价下跌时净流入;近20日主力资金累计净流入565万元,其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221539048b45007c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221539048b45007c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428366667","title":"博拓生物上涨5.38%,报24.89元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428366667","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2428366667?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:28","pubTimestamp":1713335321,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界4月17日,博拓生物盘中上涨5.38%,截至14:07,报24.89元/股,成交960.76万元,换手率0.98%,总市值26.55亿元。截至9月30日,博拓生物股东户数9443,人均流通股4264股。2023年1月-9月,博拓生物实现营业收入3.12亿元,同比减少82.23%;归属净利润9152.79万元,同比减少89.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171428518787945d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171428518787945d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428376360","title":"博拓生物大幅上涨5.38% 主力净流入270万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428376360","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2428376360?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:07","pubTimestamp":1713334061,"startTime":"0","endTime":"0","summary":"04月17日,博拓生物股价大幅上涨,截至14点07分,博拓生物上涨5.38%,报24.89元/股,成交953万元,换手率0.97%,振幅4.57%。资金动向截止发稿,博拓生物获得主力净流入270万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示,今年三季报,博拓生物实现营业收入3.12亿元,同比减少82.23%,净利润为9,152.79万元,同比减少89.66%,基本每股收益为0.86元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526497a5360d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526497a5360d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427866543","title":"博拓生物大跌5.42% 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2427866543","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427866543?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:37","pubTimestamp":1713231421,"startTime":"0","endTime":"0","summary":"04月16日,博拓生物股价大幅下跌,截至09点37分,博拓生物下跌5.42%,报22.88元/股,创近2月新低,成交254万元,换手率0.27%,振幅5.42%。资金动向截止发稿,博拓生物获得主力净流入70万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示,今年三季报,博拓生物实现营业收入3.12亿元,同比减少82.23%,净利润为9,152.79万元,同比减少89.66%,基本每股收益为0.86元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161015457920c5bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161015457920c5bd&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-09-08","address":"浙江省杭州市余杭区中泰街道富泰路17号","stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":0.1841},{"period":"3month","weight":0.1617},{"period":"6month","weight":-0.0332},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":-0.0291}],"companyName":"杭州博拓生物科技股份有限公司","boardCode":"AI0027","perCapita":"5247股","boardName":"医药制造业","registeredCapital":"10666万元","compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":0.0418},{"period":"3month","weight":0.0977},{"period":"6month","weight":0.0311},{"period":"1year","weight":-0.0498},{"period":"ytd","weight":0.0574}],"survey":" 杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。2023年5月,公司成为浙江省2023年度第一批“专精特新”企业。","serverTime":1715788826732,"listedPrice":34.55,"stockholders":"7673人(较上一季度减少12.00%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博拓生物,688767,博拓生物股票,博拓生物股票老虎,博拓生物股票老虎国际,博拓生物行情,博拓生物股票行情,博拓生物股价,博拓生物股市,博拓生物股票价格,博拓生物股票交易,博拓生物股票购买,博拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}